Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Indonesian Journal on Medical Science (IJMS)
Adilla Fitria Wulandari
Politeknik Kesehatan Bhakti Mulia
Chemical Engineering, Chemistry & Bioengineering Health Professions Medicine & Pharmacology Nursing Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Rasionalitas Penggunaan Obat Antihipertensi Pasien Jantung Koroner Instalasi Rawat Jalan Rumah Sakit Nirmala Suri Anom Parmadi; Sri Rejeki; Adilla Fitria Wulandari
Indonesian Journal on Medical Science Vol 10 No 2 (2023): IJMS 2023
Publisher : Unit Penelitian dan Pengabdian Masyarakat Politeknik Kesehatan Bhakti Mulial

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55181/ijms.v10i2.405

Abstract

Antihypertensive drugs for coronary heart disease patients require proper treatment and attention to avoid becoming a major medical issue, given the relatively high incidence rate. A risk factor for coronary heart disease is a history of hypertension. Rational evaluation of antihypertensive drug use aims to ensure appropriate medication for coronary heart disease patients. Rationality criteria for drug use include proper indication, drug selection, dosage, and patient suitability. This study aims to evaluate the rationality of antihypertensive drug use in coronary heart disease patients at the Outpatient Clinic of Nirmala Suri Hospital. The research adopts a non-experimental, descriptive analytical design with a retrospective study approach involving coronary heart disease patients from December 2020 to February 2021. Simple random sampling technique was used, and 85 samples were obtained. The research instrument was a checklist. The evaluation results of antihypertensive drug use in coronary heart disease patients at the Outpatient Clinic of Nirmala Suri Hospital from December 2020 to February 2021, based on JNC VIII guidelines and the standard guidelines of the Indonesian Ministry of Health, show rationality with percentages of 100% for patient suitability, indication, and drug selection, and 90.59% for proper dosage.
Co-Authors Anom Parmadi Sri Rejeki